市場調査レポート
商品コード
1291595
水頭症シャント市場:世界の産業動向、シェア、規模、成長機会、2023-2028年予測Hydrocephalus Shunts Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
水頭症シャント市場:世界の産業動向、シェア、規模、成長機会、2023-2028年予測 |
出版日: 2023年05月29日
発行: IMARC
ページ情報: 英文 142 Pages
納期: 2~3営業日
|
世界の水頭症シャント市場は、2022年に4億3,360万米ドルに達しました。今後、IMARC Groupは、2023年から2028年の間に3.99%の成長率(CAGR)を示し、2028年までに5億6,180万米ドルに達すると予想しています。
水頭症シャントとは、脳内に体液が溜まり、頭蓋骨内の頭蓋内圧が上昇することで起こる症状の治療で、用いられる医療機器は一般的に、バルブ、カテーテル、圧力調整バルブ、固定圧力バルブのバリエーションがあります。脳脊髄液(CSF)が生成される脳領域に挿入される柔軟なチューブです。水頭症シャントは、側脳室からCSFを排出する流入または近位カテーテル、流体の流れを制御して頭蓋内圧を調整するバルブ機構、皮膚の下を通ってCSFを導く流出または遠位カテーテルで構成されています。大脳の緊張を和らげ、肥大化した脳室を実際の大きさに戻すことを支援するものです。
大衆の間で脳や神経疾患の有病率が高まっていることが、市場の成長を促進する主な要因の1つとなっています。水頭症シャントは、先天性異常、脳や神経の損傷、中枢神経系(CNS)の欠陥につながる事故、生活習慣病などの発生率の上昇により、広く使用されています。また、頭部の肥大や脳の損傷につながる可能性のある乳幼児の水頭症を治療するための製品需要が増加していることも、市場の成長に好影響を与えています。さらに、脳脊髄液に対するサイフォン効果を回避するのに役立つアンチサイフォン装置の開発など、さまざまな技術的進歩が市場成長の推進力となっています。また、脳脊髄液の流れを制御し、誤った方向への移動を防止するためのプログラマブルバルブの開発も、市場の成長にプラスの影響を及ぼしています。その他、ヘルスケア産業の著しい成長、水頭症シャントに関する認識を広めるための様々な政府イニシアチブの実施などが、全世界で市場のさらなる成長を促進すると予想されます。
The global hydrocephalus shunts market reached US$ 433.6 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 561.8 Million by 2028, exhibiting a growth rate (CAGR) of 3.99% during 2023-2028.
Hydrocephalus shunts refer to a medical device used for treating a condition that occurs when fluid builds up in the brain and results in increased intracranial pressure within the skull. It is commonly available in valves, catheters, adjustable pressure valves and fixed pressure valve variants. It is a flexible tube placed into the brain area where cerebrospinal fluid (CSF) is produced. Hydrocephalus shunts consist of an inflow or proximal catheter that drains CSF from the lateral ventricles, a valve mechanism that regulates intracranial pressure by controlling fluid flow and an outflow or distal catheter that runs under the skin and directs CSF. It assists in soothing the tension on the cerebrum and returning the brain's enlarged ventricles to their actual size.
The increasing prevalence of brain and neurological disorders among the masses is one of the key factors driving the growth of the market. Hydrocephalus shunts are widely used due to the rising incidence of congenital abnormalities, brain and nerve injuries, accidents leading to central nervous system (CNS) defects and lifestyle diseases. Additionally, the increasing product demand to treat hydrocephalus among infants that could lead to enlargement of the head and damaging brain is favoring the market growth. Moreover, various technological advancements, such as the development of anti-siphon devices that assist in avoiding siphon effects over cerebrospinal fluid, are providing a thrust to the market growth. In line with this, the development of programmable valves for controlling the flow of cerebrospinal fluid and preventing it from moving in the wrong direction is positively impacting the market growth. Other factors, including significant growth in the healthcare industry, along with the implementation of various government initiatives to spread awareness regarding hydrocephalus shunts, are anticipated to drive the market toward growth further across the globe.
IMARC Group provides an analysis of the key trends in each sub-segment of the global hydrocephalus shunts market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, product type, age group and end user.
Ventriculo-Peritoneal
Ventriculo-Atrial
Ventriculo-Pleural
Lumbo-Peritoneal
Hydrocephalus Valves
Adjustable Pressure Valves
Fix Pressure Valves
Hydrocephalus Catheters
Infants
Children
Adults
Hospitals
Ambulatory Surgical Centers
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Argi Group, B. Braun Melsungen AG, Christoph Miethke GmbH & Co. KG, G. Surgiwear Ltd., HLL Lifecare Limited, Integra LifeSciences, Kaneka Medix Corporation (Kaneka Corporation), Medtronic Plc, Natus Medical Incorporated, Sophysa, Spiegelberg GmbH & Co. KG (SHS Medizintechnik Holding GmbH) and TKB Corporation.
Key Questions Answered in This Report
1. What was the size of the global hydrocephalus shunts market in 2022?
2. What is the expected growth rate of the global hydrocephalus shunts market during 2023-2028?
3. What has been the impact of COVID-19 on the global hydrocephalus shunts market?
4. What are the key factors driving the global hydrocephalus shunts market?
5. What is the breakup of the global hydrocephalus shunts market based on the type?
6. What is the breakup of the global hydrocephalus shunts market based on the product type?
7. What is the breakup of the global hydrocephalus shunts market based on the age group?
8. What is the breakup of the global hydrocephalus shunts market based on the end user?
9. What are the key regions in the global hydrocephalus shunts market?
10. Who are the key players/companies in the global hydrocephalus shunts market?